Skip to main content
Veterinary Medicines

Tyloveto-20 200 mg/ml Oplossing voor injectie

Authorised
  • Tylosin tartrate

Product identification

Medicine name:
Tyloveto-20 200 mg/ml Oplossing voor injectie
Tyloveto-20 200 mg/ml Solution injectable
Tyloveto-20 200 mg/ml Injektionslösung
Active substance:
  • Tylosin tartrate
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Tylosin tartrate
    200000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        49
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA90
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Tyloveto-20 12 Vials with 100 ml of Solution for injection
  • Tyloveto-20 1 Vial with 100 ml of Solution for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V162102
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/02/2023
French (PDF)
Published on: 21/02/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 21/02/2023
French (PDF)
Published on: 21/02/2023
German (PDF)
Published on: 21/02/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."